# Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/atezolizumab-combined-with-bevacizumab-and-platinum-based-therapy-for-platinum/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jean‐Emmanuel Kurtz,Éric Pujade-Lauraine,Ana Oaknin,Lisa Belin,Katharina Leitner,David Cibula,Hannelore Denys,Ora Rosengarten,Manuel Rodrigues,Nikolaus de Gregorio,Jerónimo Martínez,Edgar Petru,Roman Kocián,Ignace Vergote,Patricia Pautier,Barbara Schmalfeldt,Lydia Gaba,Stephan Polterauer,Marie‐Ange Mouret‐Reynier,Jalid Sehouli,Cristina Churruca,Frédèric Selle,Florence Joly,Véronique D’Hondt,Émilie Bultot-Boissier,Coriolan Lebreton,Jean‐Pierre Lotz,Rémy Largillier,Pierre‐Etienne Heudel,Florian Heitz,on behalf of the ATALANTE/ENGOT-ov29 Investigators,Jean‐Emmanuel Kurtz,Sophie Abadie‐Lacourtoisie,Cyril Abdeddaim,J. Alexandre,P. Augereau,D. Avenin,M. Azémar,Nabil Baba-Hamed,Olivia Bally,Jérôme Barrière,Fernando Bazán,Dominique Berton,Nathalie Bonichon-Lamichhane,Nathalie Bonnin,Elouen Boughalem,R. Boustany Grenier,Pierre-Emmanuel Brachet,Fabien Brocard,Émilie Bultot-Boissier,Maria Cappiello-Bataller,H. Castanie,L. Chaigneau,Camille Chakiba,Dorothée Chocteau-Bouju,Pierre Combe,Aurélie Comte,Elodie Coquan,Cristina Costan,P. Cottu,L. Crouzet,H. Curé,Jérôme Dauba,Hussain Dawood,Laure De Cock,T. De La Motte Rouge,C. Debelleix,Catherine Delbaldo,Martin Demarchi,Marion Deslandres,Raymond Despax,Véronique D’Hondt,Anne Françoise DILLIES-LEGRAIN,A Donnadieu,C. Dubot,Jean Marc Extra,Michel Fabbro,Claire Falandry,F. Fiteni,Anne Floquet,Philippe Follana,Jean‐Sébastien Frenel,G. Freyer,D. Garbay-Decoopman,Céline Gavoille,V. Girre,Laurence Gladieff,F. Goldwasser,Alain Gratet,Jean‐Christophe Grenier,Anne‐Claire Hardy‐Bessard,Pierre‐Etienne Heudel,Florence Joly,A. Jouinot,Emilie Kalbacher,Marie‐Christine Kaminsky,Laurence Lancry-Lecomte,R. Largillier,Fanny Le Du,Alexandra Léary |
| Citations | 109 |
| DOI | 10.1200/jco.23.00529 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.00529?role=tab |
| OpenAlex ID | https://openalex.org/W4386244514 |
| PMID | 37643382 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Pierre Combe](https://scholariq.org/researchers/pierre-combe/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.